HK1171811A1 - 用於癌症診斷的尿生物標誌物 - Google Patents

用於癌症診斷的尿生物標誌物

Info

Publication number
HK1171811A1
HK1171811A1 HK12112688.8A HK12112688A HK1171811A1 HK 1171811 A1 HK1171811 A1 HK 1171811A1 HK 12112688 A HK12112688 A HK 12112688A HK 1171811 A1 HK1171811 A1 HK 1171811A1
Authority
HK
Hong Kong
Prior art keywords
cancer diagnosis
urinary biomarkers
biomarkers
urinary
diagnosis
Prior art date
Application number
HK12112688.8A
Other languages
English (en)
Inventor
Irun R Cohen
Meirav Pevsner-Fischer
David Margel
Jack Baniel
Ofer Yossepowitch
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of HK1171811A1 publication Critical patent/HK1171811A1/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/5428—IL-10
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/5437—IL-13
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/545—IL-1
HK12112688.8A 2009-08-03 2012-12-07 用於癌症診斷的尿生物標誌物 HK1171811A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23076309P 2009-08-03 2009-08-03
PCT/IL2010/000626 WO2011016031A2 (en) 2009-08-03 2010-08-03 Urinary biomarkers for cancer diagnosis

Publications (1)

Publication Number Publication Date
HK1171811A1 true HK1171811A1 (zh) 2013-04-05

Family

ID=43425849

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12112688.8A HK1171811A1 (zh) 2009-08-03 2012-12-07 用於癌症診斷的尿生物標誌物

Country Status (5)

Country Link
US (2) US8748118B2 (zh)
EP (2) EP2462449B1 (zh)
DK (1) DK2462449T3 (zh)
HK (1) HK1171811A1 (zh)
WO (1) WO2011016031A2 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9249467B2 (en) 2011-09-16 2016-02-02 Steven Goodison Bladder cancer detection composition, kit and associated methods
GB201305940D0 (en) * 2013-04-02 2013-05-15 Immunovia Ab Methods and arrays for use in the same
ITUA20161418A1 (it) * 2016-03-07 2017-09-07 Univ Degli Studi Di Torino Biomarcatori urinari per la diagnosi del carcinoma della prostata
US20190271703A1 (en) * 2016-10-26 2019-09-05 Duke University Biomarkers and treatments for metastatic cancer
GB201818744D0 (en) * 2018-11-16 2019-01-02 Randox Laboratories Ltd Detection of bladder cancer

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7807532A (nl) 1978-07-13 1980-01-15 Akzo Nv Metaal-immunotest.
AU2706384A (en) 1983-05-06 1984-11-08 Monoclonal Antibodies Inc. Colorimetric immunoassay on solid surface
US4632901A (en) 1984-05-11 1986-12-30 Hybritech Incorporated Method and apparatus for immunoassays
US4786589A (en) 1986-08-18 1988-11-22 Huntington Medical Research Institute Immunoassay utilizing formazan-prelabeled reactants
US5221612A (en) 1989-03-03 1993-06-22 Board Of Regents, The University Of Texas System Unique protein marker for bladder cancer
KR910014706A (ko) 1990-01-10 1991-08-31 원본미기재 세척이 필요없는 개량된 이뮤노어세이(immunoassay)장치
US6280956B1 (en) 1995-11-03 2001-08-28 University Of Pittsburgh Antibodies to bladder cancer nuclear matrix proteins and their use
US6811995B1 (en) 1996-04-26 2004-11-02 Children's Medical Center Corporation Non-invasive enzyme screen for cancer
US6261791B1 (en) 1997-03-10 2001-07-17 The Regents Of The University Of California Method for diagnosing cancer using specific PSCA antibodies
US7776518B2 (en) 2001-01-12 2010-08-17 Yale University Detection of survivin in the biological fluids of cancer patients
US7332290B2 (en) 2001-08-02 2008-02-19 The Regents Of The University Of Michigan Dectection of AMACR cancer markers in urine
IL148401A0 (en) * 2002-02-26 2002-09-12 Hadasit Med Res Service Hsp70-derived peptides and uses thereof in the diagnosis and treatment of autoimmune diseases
AU2003282709A1 (en) 2002-10-04 2004-05-04 Sloan Kettering Institute For Cancer Research Gene expression profiling of bladder cancer
AU2005216236A1 (en) 2004-02-25 2005-09-09 The United States Of America As Represented By The Department Of Veterans Affairs Methods for diagnosing and treating bladder cancer
WO2006034278A2 (en) 2004-09-21 2006-03-30 Matritech, Inc. Methods and compositions for detecting cancer using components of the u2 spliceosomal particle
US8343461B2 (en) * 2006-03-08 2013-01-01 Wake Forest University Health Sciences Molecular signature of cancer
US20080206139A1 (en) * 2006-11-03 2008-08-28 The Penn State Research Foundation Delivery system for diagnostic and therapeutic agents
WO2009029601A2 (en) * 2007-08-24 2009-03-05 Regents Of The University Of Minnesota Receptor-targeting reagents
WO2009052376A1 (en) 2007-10-18 2009-04-23 Musc Foundation For Research Development Methods for the diagnosis of genitourinary cancer
US8771962B2 (en) * 2008-10-02 2014-07-08 Sarka O. Southern Health test for a broad spectrum of health problems
US20100240546A1 (en) * 2009-03-20 2010-09-23 Samuel Chun Lap Lo Use of biomarkers for the diagnosis and prognosis of lung cancer
JP5736370B2 (ja) * 2009-06-25 2015-06-17 ネステク ソシエテ アノニム 過敏性腸症候群の診断方法

Also Published As

Publication number Publication date
WO2011016031A2 (en) 2011-02-10
US20120149043A1 (en) 2012-06-14
DK2462449T3 (en) 2017-01-09
EP2462449A2 (en) 2012-06-13
WO2011016031A3 (en) 2011-10-13
EP3109638A1 (en) 2016-12-28
EP2462449B1 (en) 2016-09-21
US20140323355A1 (en) 2014-10-30
US8748118B2 (en) 2014-06-10

Similar Documents

Publication Publication Date Title
EP2382331A4 (en) KREBSBIOMARKER
IL216720A (en) Biological markers for assessing kidney disease
EP2423323A4 (en) METHOD OF TUMOR ASSESSMENT
PL2438445T3 (pl) Sposoby diagnozowania raków gruczołu krokowego
EP2515114A4 (en) METHOD FOR THE DIAGNOSIS OF MALIGNANT TUMOR
GB201012590D0 (en) Methods for diagnosing cancer
HK1171811A1 (zh) 用於癌症診斷的尿生物標誌物
GB0903417D0 (en) Biomarkers
GB0921329D0 (en) Biomarker
GB0918722D0 (en) Anti cancer agent
EP2486154A4 (en) DIAGNOSTIC AND PROGNOSTIC MARKERS FOR CANCER
GB0915736D0 (en) Biomarkers
EP2501845A4 (en) KREBSBIOMARKER
PT2356252E (pt) Método para a deteção urinária do cancro da bexiga
IL217333A0 (en) Biomarker
GB0903391D0 (en) Biomarkers
EP2496699A4 (en) DIAGNOSTIC ANALYZES FOR CHORDOPOXVIRUS
IL217335A0 (en) Biomarker er2 for gynaecological cancer
GB201004304D0 (en) Biomarkers for prostate cancer
EP2403963A4 (en) BIOMARKER AND TREATMENT FOR CANCER
IL217564A0 (en) Urinary biomarkers for cancer diagnosis
GB0922236D0 (en) Biomarkers
ZA201103566B (en) Biomarker for diagnosing cancer
IL245432A0 (en) A method for diagnosing cancer
GB0905090D0 (en) Biomarkers

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200730